EUCTR2009-012099-29-FI进行中（未招募）不适用
Kroonista lymfaattista leukemiaa (KLL) sairastavien potilaiden pneumokokki-vasta-aineiden säilyvyys ja muistisolujen toiminta konjugaattirokotteen jälkeen. - KLLmuisti
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Aiemmin Prevenar-rokoteen saaneet KLL-potilaat ja verrokit. (seurantatutkimus)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Pneumokokkipolysakkaridirokote annettu edellisen Prevenar-rokotteen jälkeen (5 v sisällä)
- •Iv-immunoglobuliinikorvaushoitoa saavat potilaat.
- •Potilaat, joilla kortikosteroidihoito (vastaten > 20 mg Prednisolonia vrk:ssa)
研究者
相似试验
进行中（未招募）
1 期
Treatment of blood cancer with the use of a drug active against herpesvirusesChronic lymphocytic leukemiaMedDRA version: 14.1Level: LLTClassification code 10008976Term: Chronic lymphocytic leukemiaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2010-021786-78-ATMedizinische Universität Wien
已完成
不适用
CML V - chronic phase Chronic Myeloid LeukaemiaeukaemiaMyeloid leukaemiaCancerISRCTN68784584niversity of Oxford (UK)800
进行中（未招募）
不适用
A Study to Assess Change in Functioning and Health Related Quality of Life in Adult Participants With Chronic Lymphocytic Leukemia (CLL) Receiving Oral Treatments in Routine Clinical Practice in SpainChronic Lymphocytic LeukemiaNCT06125795AbbVie146
已完成
不适用
CML IV - Chronic phase chronic myeloid leukaemia/CML 2000eukaemiaChronic myeloid leukaemiaCancerISRCTN61147621Medical Research Council (MRC) (UK)800
已完成
2 期
Childrens Cancer and Leukemia Study Group (CCLSG) ALL2004 : A Multi-Center Phase II Study in Children with Newly Diagnosed Acute Lymphoblastic LeukemiaChildhood acute lymphoblastic leukemiaJPRN-UMIN000010488Childhood Cancer and Leukemia Study Group (CCLSG)230